The Collaborative Amish Aging and Memory Project (CAAMP) is an ongoing, multi-site longitudinal study focused on cognitive function and age-related traits within Amish communities in Ohio and Indiana. The project targets a set of primary phenotypes including Alzheimer disease and related dementias (ADRD), successful aging, and other late-life conditions. By combining detailed clinical phenotyping with deep family and molecular data, CAAMP aims to clarify genetic and biological contributors to cognitive outcomes in a founder population.
CAAMP collects harmonized clinical and cognitive assessments across participating sites together with structured family history and multigenerational pedigree information. Cognitive diagnoses are determined through consensus adjudication panels that review clinical examinations, performance on cognitive tests, functional status, and informant reports. The cohort includes extensive biospecimen collection and biomarker measurement, and molecular data layers include genome-wide genotyping and whole-genome sequencing for many participants.
Data types assembled within CAAMP include:
Longitudinal follow-up and repeat biospecimen sampling are available for subsets of participants, facilitating studies of temporal change in cognition and biomarkers. The study procedures and data collection were approved by institutional review boards at Case Western Reserve University and the University of Miami, and participant consent processes were documented according to ethical requirements.
Enrollment and baseline characteristics reported to date include 3,978 participants with a mean age of 78.6 years (SD = 7.9). The cohort is 59.1% female, and 83% of participants reported an education level at or below the eighth grade. Of the total enrollees, 2,928 participants have undergone the consensus-adjudication process for cognitive status; the remaining 1,050 lacked detailed cognitive evaluations at enrollment.
Among those with adjudicated cognitive status at the most recent assessment, classification proportions were:
The cohort contains longitudinal cognitive data for participants with repeated assessments, and multiple biospecimen sample types and plasma biomarker measurements are available for subsets, supporting multimodal analyses of cognition and aging.
CAAMP leverages the demographic and genetic features of an American founder population to investigate the genetic architecture and biological pathways underlying cognition and late-life disease. By integrating consensus-based clinical diagnoses with pedigree and genomic data, the project is positioned to identify both risk factors and potential protective mechanisms relevant to Alzheimer disease and other age-related conditions.
The availability of longitudinal cognitive assessments and repeated biospecimens allows investigation of cognitive trajectories and biomarker dynamics over time. The rich pedigree information combined with genome-wide and whole-genome sequence data can be used to perform family-based genetic analyses and to contextualize population-specific variants that may influence disease susceptibility or resilience.
CAAMP’s design supports future work aimed at distinguishing genetic contributions to disease versus successful aging, and at identifying molecular markers associated with cognitive decline or protection. Continued follow-up and broader phenotypic and molecular characterization of participants will enhance opportunities to dissect the biology of late-life cognitive outcomes.
Ethical approval for CAAMP activities was obtained from the institutional review boards of Case Western Reserve University and the University of Miami. The authors report that participant consent procedures and relevant reporting guidelines were followed. Data generated by the study may be made available on reasonable request to the study authors, subject to coordination and approval with the relevant IRBs.
The work reported was supported by the National Institutes of Health, including the National Institute on Aging and the National Institute of Environmental Health Sciences, with grant identifiers reported in the source material. The authors have declared no competing interests.